Physician

Jeffrey Peterson, MD

According to 2025 Medicare claims, Jeffrey Peterson, MD (NPI: 1578889945) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is TYRIE LEE JENKINS, M.D., INC. (NPI: 1295791135; TIN: 990332079) and primary practice location at 96814-3139.

Peterson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 823 traditional Medicare patients, billed 4,400 HCPCS/CPT codes, and received $319,365 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,929 prescription claims across 630 beneficiaries totaling $697,185 in drug costs, led by Vyzulta (Latanoprostene Bunod). Open Payments data shows 49 records totaling $10,912. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,335 to $319,365. Similarly, Part D prescription costs have risen steadily, from $696 to $697,185. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$175K$349K2015 Medicare payment: $3,335 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $146,395 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $211,579 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $316,604 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $349,233 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $256,157 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $297,000 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $302,618 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $341,988 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $319,365 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153357$3,335
20164122,004$146,395
20175662,980$211,579
20188623,780$316,604
20198993,923$349,233
20207513,470$256,157
20217723,811$297,000
20228224,064$302,618
20238734,536$341,988
20248234,400$319,365

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$349K$697K2015 Drug cost: $696 (USD; Tot_Drug_Cst)2016 Drug cost: $165,159 (USD; Tot_Drug_Cst)2017 Drug cost: $356,011 (USD; Tot_Drug_Cst)2018 Drug cost: $466,370 (USD; Tot_Drug_Cst)2019 Drug cost: $593,147 (USD; Tot_Drug_Cst)2020 Drug cost: $632,810 (USD; Tot_Drug_Cst)2021 Drug cost: $676,956 (USD; Tot_Drug_Cst)2022 Drug cost: $644,285 (USD; Tot_Drug_Cst)2023 Drug cost: $665,668 (USD; Tot_Drug_Cst)2024 Drug cost: $697,185 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R12$696
2016250924$165,159
20173451,774$356,011
20184342,252$466,370
20194482,417$593,147
20204522,336$632,810
20214902,464$676,956
20225112,455$644,285
20235522,636$665,668
20246302,929$697,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more425444$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more392529$74
92083Exam of visual field with extended testing382439$46
92250Photography of the retina521546$27
92133Imaging of optic nerve417498$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyzultaLatanoprostene Bunod16210,107$113,517
RocklatanNetarsudil Mesylat/Latanoprost1566,573$95,928
RestasisCyclosporine674,620$90,284
LumiganBimatoprost865,847$62,588
RhopressaNetarsudil Mesylate984,881$57,655

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$10,912Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey Peterson, MD?

Tedicare shows public-source Medicare data for Jeffrey Peterson, MD (NPI 1578889945), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Peterson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Peterson, MD?

Jeffrey Peterson, MD is linked to TYRIE LEE JENKINS, M.D., INC. (billing NPI 1295791135) in the available physician profile data.

Does Jeffrey Peterson, MD have Open Payments data?

Jeffrey Peterson, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.